EVALUATION OF MTX 5-FU SEQUENTIAL CHEMOTHERAPY UTILIZED MTT ASSAY FORGASTROINTESTINAL CANCER/

Citation
M. Tani et al., EVALUATION OF MTX 5-FU SEQUENTIAL CHEMOTHERAPY UTILIZED MTT ASSAY FORGASTROINTESTINAL CANCER/, Oncology Reports, 3(1), 1996, pp. 41-43
Citations number
16
Categorie Soggetti
Oncology
Journal title
ISSN journal
1021335X
Volume
3
Issue
1
Year of publication
1996
Pages
41 - 43
Database
ISI
SICI code
1021-335X(1996)3:1<41:EOM5SC>2.0.ZU;2-O
Abstract
Fresh human gastrointestinal cancer cells are more resistant to antica ncer drugs compared to other cancer cells, and the selection of antica ncer drugs for cancer chemotherapy is important. In the present study, it is demonstrated that MTX enhanced the chemosensitivity of 5-FU, es pecially, in the tumor cells with less than 70% inhibition ratio by th e MTT assay. It has been reported that MTX/5-FU sequential chemotherap y was one of the effective chemotherapies against gastric cancer and c olon cancer, and it is possible to anticipate the efficacy of MTX/5-FU sequential chemotherapy by the MTT assays.